Literature DB >> 21447301

[Mesenchymal stem cells: weapons or dangers for cancer treatment?].

Gwendal Lazennec1.   

Abstract

Mesenchymal stem cells (MSC) have attracted recent attention for their cell therapy potential, based in particular on their immunosuppressive properties, which have served as the basis for the treatment of autoimmune diseases. Interestingly, MSC have been used in cell therapy strategies to deliver therapeutical genes. Cell therapy approaches taking advantages of MSC have been proposed, as MSC display a potential tropsim for tumors. However, all these strategies raise a series of questions about the safety of MSC, as MSC could enhance tumor growth and metastasis. This review summarizes recent findngs about MSC in carcinogenesis.
© 2011 médecine/sciences - Inserm / SRMS.

Entities:  

Mesh:

Year:  2011        PMID: 21447301     DOI: 10.1051/medsci/2011273285

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  1 in total

Review 1.  Cell-derived membrane biomimetic nanocarriers for targeted therapy of pulmonary disease.

Authors:  Xixi Zheng; Tianyuan Zhang; Ting Huang; Yanjun Zhou; Jianqing Gao
Journal:  Int J Pharm       Date:  2022-04-18       Impact factor: 6.510

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.